Logotipo del repositorio
Logotipo del repositorio
 

Reporte de caso: Enfermedad de Wilson, un reto diagnóstico

Vista sencilla de ítem
dc.contributor.authorNavarro Navarro, Jaime
dc.date.accessioned2020-02-11T19:31:55Z
dc.date.available2020-02-11T19:31:55Z
dc.date.issued2019
dc.description.abstractLa enfermedad de Wilson es un trastorno genético de transmisión autosómica recesiva, producida por la mutación del gen ATP7B. Es considerada una enfermedad rara o huérfana debido a su baja prevalencia. Sin embargo, es una enfermedad crónica que puede llevar al deterioro de la calidad de vida del paciente poniéndolo en riesgo de muerte, por lo que se considera una enfermedad catastrófica. El gen ATP7B es determinante en el proceso de eliminación del cobre del organismo, por tanto, la mutación génica implica a su acumulación principalmente en el hígado y Sistema Nervioso Central (SNC). El diagnóstico de la enfermedad en etapas tempranas es vital para el control de los síntomas y evitar el deterioro hepático, neurológico y/o psiquiátrico del paciente. Sin embargo, la inespecificidad de los síntomas, así como la tardía edad de inicio de estos, dificulta su diagnóstico oportuno. La detección de los signos clínicos de la enfermedad y las anomalías genéticas asociadas, son necesarias para iniciar un tratamiento efectivo, si bien la enfermedad no es curable, el tratamiento farmacológico oportuno con medicamentos quelantes, minimizan los efectos del cobre en el organismo.spa
dc.description.abstractWilson's disease is an autosomal recessive genetic transmission disorder, caused by the mutation of the ATP7B gene. It is considered a rare or orphan disease due to its low prevalence. However, it is a chronic disease that can lead to the deterioration of the patient's quality of life putting him at risk of death, which is why it is considered a catastrophic disease. The ATP7B gene is decisive in the process of eliminating copper from the body, therefore, gene mutation leads to its accumulation mainly in the liver and Central Nervous System (CNS). The diagnosis of the disease in early stages is vital for the control of the symptoms and to avoid the hepatic, neurological and / or psychiatric deterioration of the patient. However, the non-specificity of the symptoms, as well as the late age of onset of these, hinders their timely diagnosis. The detection of the clinical signs of the disease and the associated genetic abnormalities, are necessary to initiate an effective treatment, although the disease is not curable, the timely pharmacological treatment with chelating drugs minimizes the effects of copper in the organismeng
dc.format.mimetypepdfspa
dc.identifier.urihttps://hdl.handle.net/20.500.12442/4724
dc.language.isospaspa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias Básicas y Biomédicasspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectEnfermedades huérfanasspa
dc.subjectATPasas Transportadoras de Cobrespa
dc.subjectGenotipospa
dc.subjectEnfermedad de Wilsonspa
dc.subjectProteína ATP7Aspa
dc.subjectOrphan diseaseseng
dc.subjectCopper absorptioneng
dc.subjectGenotypeeng
dc.subjectWilson's diseaseeng
dc.subjectATP7B geneeng
dc.titleReporte de caso: Enfermedad de Wilson, un reto diagnósticospa
dc.typeOtherspa
dc.type.driverOtherspa
dcterms.referencesGuerra Montero L, Ortega Álvarez F, Sumire Umeres J, Cok García J. Enfermedad de Wilson: forma hepática . [Internet]. Vol. 35, Revista de Gastroenterología del Perú . 2015. p. 361-5. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292015000400012spa
dcterms.referencesForuny Olcina JR, Boixeda de Miquel D. Enfermedad de Wilson. Rev Española Enfermedades Dig [Internet]. 2010;102:53-4. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082010000100009&nrm=isospa
dcterms.referencesMillán Jiménez A, Ruiz Moreno M. Enfermedad de Wilson. En: Ergón, editor. Protocolos diagnóstico-terapéuticos de Gastroenterología, Hepatología y Nutrición Pediátrica. 2012.spa
dcterms.referencesStenson PD, Mort M, Ball E V., Evans K, Hayden M, Heywood S, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet [Internet]. 2017;136(6):665-77. Disponible en: http://link.springer.com/10.1007/s00439-017-1779-6eng
dcterms.referencesCoffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, et al. A genetic study of Wilson’s disease in the United Kingdom. Brain [Internet]. mayo de 2013;136(5):1476-87. Disponible en: https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/awt035eng
dcterms.referencesMinisterio de Salud y Protección social. Resolución 2048 [Internet]. Bogotá; 2015. Disponible en: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución 2048 de 2015.pdfspa
dcterms.referencesMinisterio de Salud y Protección social. Ley 1392 [Internet]. Bogotá; 2010. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/ley-1392-de-2010.pdfspa
dcterms.referencesMinisterio de Salud y Protección social. Decreto 1954 [Internet]. Bogotá; 2012. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/Decreto-1954-de-2012.PDFspa
dcterms.referencesBandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet Neurol [Internet]. 2015;14(1):103-13. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1474442214701905eng
dcterms.referencesFerenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing . Hum Genet [Internet]. 2006;120(2):151-9. Disponible en: http://link.springer.com/10.1007/s00439-006-0202-5eng
dcterms.referencesDzieżyc K, Karliński M, Litwin T, Członkowska A. Compliant treatment with anti-copper agents prevents clinically overt Wilson’s disease in pre-symptomatic patients. Eur J Neurol [Internet]. 2014;21(2):332-7. Disponible en: http://doi.wiley.com/10.1111/ene.12320eng
dcterms.referencesEASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol [Internet]. marzo de 2012;56(3):671-85. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0168827811008129eng
dcterms.referencesRoberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: An update . Hepatology [Internet]. 2008;47(6):2089-111. Disponible en: http://doi.wiley.com/10.1002/hep.22261eng
dcterms.referencesSocha P, Janczyk W, Dhawan A, Baumann U, D’Antiga L, Tanner S, et al. Wilsonʼs Disease in Children. J Pediatr Gastroenterol Nutr [Internet]. 2018;66(2):334-44. Disponible en: http://insights.ovid.com/crossref?an=00005176-201802000-00032eng
dcterms.referencesBroussolle E, Trocello J-M, Woimant F, Lachaux A, Quinn N. Samuel Alexander Kinnier Wilson. Wilson’s disease, Queen Square and neurology . Rev Neurol (Paris) [Internet]. 2013;169(12):927-35. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0035378713008916eng
dcterms.referencesCzłonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease . Nat Rev Dis Prim [Internet]. 2018;4(1):21. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30190489eng
dcterms.referencesBarbosa ER, Machado AAC, Cançado ELR, Deguti MM, Scaff M. Wilson’s Disease: a case report and a historical review . Arq Neuropsiquiatr [Internet]. 2009;67(2b):539-43. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000300036&lng=en&tlng=eneng
dcterms.referencesLópez Hernández M, Serrano Rufino M. Enfermedad de Wilson: reporte de un caso y revisión de la literatura. Med interna México [Internet]. 2007;23(5):458-63. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=18434spa
dcterms.referencesWalshe JM. History of Wilson disease. En 2017. p. 1-5. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/B978044463625600001Xeng
dcterms.referencesFerenci P. Guías de Práctica Clínica de la EASL: Enfermedad de Wilson. J Hepatol [Internet]. 2011;56:671–685. Disponible en: https://easl.eu/wp-content/uploads/2018/10/2012-Wilson_ES.pdfspa
dcterms.referencesClark Feoktistova Y. Enfermedad de Wilson. Actualidad del tema [Internet]. Vol. 38, Revista Médica Electrónica. 2016. p. 57-66. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242016000100006&nrm=isospa
dcterms.referencesSaito T. An assessment of efficiency in potential screening for Wilson’s disease . J Epidemiol Community Heal [Internet]. 1981;35(4):274-80. Disponible en: http://jech.bmj.com/cgi/doi/10.1136/jech.35.4.274eng
dcterms.referencesBachmann H, Lössner J, Biesold D. Wilson’s disease in the German Democratic Republic. I. Genetics and epidemiology . Z Gesamte Inn Med [Internet]. 1979;34(24):744-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/549306eng
dcterms.referencesXie J-J, Wu Z-Y. Wilson’s Disease in China . Neurosci Bull [Internet]. 2017;33(3):323-30. Disponible en: http://link.springer.com/10.1007/s12264-017-0107-4eng
dcterms.referencesLo C, Bandmann O. Epidemiology and introduction to the clinical presentation of Wilson disease. En 2017. p. 7-17. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/B9780444636256000021eng
dcterms.referencesCzłonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease . Nat Rev Dis Prim [Internet]. 2018;4(1):21. Disponible en: http://www.nature.com/articles/s41572-018-0018-3eng
dcterms.referencesSvetel M, Pekmezović T, Petrović I, Tomić A, Kresojević N, Ješić R, et al. Long-term outcome in Serbian patients with Wilson disease . Eur J Neurol [Internet]. 2009;16(7):852-7. Disponible en: http://doi.wiley.com/10.1111/j.1468-1331.2009.02607.xeng
dcterms.referencesBeinhardt S, Leiss W, Stättermayer AF, Graziadei I, Zoller H, Stauber R, et al. Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort . Clin Gastroenterol Hepatol [Internet]. 2014;12(4):683-9. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1542356513014304eng
dcterms.referencesCumings JN. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration . Brain [Internet]. 1948;71(Pt. 4):410-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18124738eng
dcterms.referencesGomes A, Dedoussis G V. Geographic distribution of ATP7B mutations in Wilson disease . Ann Hum Biol [Internet]. 2016;43(1):1-8. Disponible en: http://www.tandfonline.com/doi/full/10.3109/03014460.2015.1051492eng
dcterms.referencesLang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide . Nat Med [Internet]. 2007;13(2):164-70. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17259995eng
dcterms.referencesLetelier ME, Sánchez-Jofré S, Peredo-Silva L, Cortés-Troncoso J, Aracena-Parks P. Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects . Chem Biol Interact [Internet]. 2010;188(1):220-7. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0009279710003959eng
dcterms.referencesMufti AR, Burstein E, Csomos RA, Graf PCF, Wilkinson JC, Dick RD, et al. XIAP Is a Copper Binding Protein Deregulated in Wilson’s Disease and Other Copper Toxicosis Disorders . Mol Cell [Internet]. 2006;21(6):775-85. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1097276506000815eng
dcterms.referencesHuster D, Finegold MJ, Morgan CT, Burkhead JL, Nixon R, Vanderwerf SM, et al. Consequences of Copper Accumulation in the Livers of the Atp7b−/− (Wilson Disease Gene) Knockout Mice . Am J Pathol [Internet]. 2006;168(2):423-34. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002944010621037eng
dcterms.referencesMa J, Betts NM. Zinc and Copper Intakes and Their Major Food Sources for Older Adults in the 1994–96 Continuing Survey of Food Intakes by Individuals (CSFII) . J Nutr [Internet]. 2000;130(11):2838-43. Disponible en: https://academic.oup.com/jn/article/130/11/2838/4686136eng
dcterms.referencesRussell K, Gillanders LK, Orr DW, Plank LD. Dietary copper restriction in Wilson’s disease. Eur J Clin Nutr [Internet]. 2018;72(3):326-31. Disponible en: https://doi.org/10.1038/s41430-017-0002-0eng
dcterms.referencesMaryon EB, Molloy SA, Kaplan JH. Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1 . Am J Physiol Physiol [Internet]. 2013;304(8):C768-79. Disponible en: http://www.physiology.org/doi/10.1152/ajpcell.00417.2012eng
dcterms.referencesLlanos RM, Michalczyk AA, Freestone DJ, Currie S, Linder MC, Ackland ML, et al. Copper transport during lactation in transgenic mice expressing the human ATP7A protein . Biochem Biophys Res Commun [Internet]. 2008;372(4):613-7. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006291X08009881eng
dcterms.referencesHatori Y, Yan Y, Schmidt K, Furukawa E, Hasan NM, Yang N, et al. Neuronal differentiation is associated with a redox-regulated increase of copper flow to the secretory pathway . Nat Commun [Internet]. 2016;7(1):10640. Disponible en: http://www.nature.com/articles/ncomms10640eng
dcterms.referencesBaker ZN, Cobine PA, Leary SC. The mitochondrion: a central architect of copper homeostasis. Metallomics [Internet]. 2017;9(11):1501-12. Disponible en: http://xlink.rsc.org/?DOI=C7MT00221Aeng
dcterms.referencesXiao Z, Brose J, Schimo S, Ackland SM, La Fontaine S, Wedd AG. Unification of the copper(I) binding affinities of the metallo-chaperones Atx1, Atox1, and related proteins: detection probes and affinity standards . J Biol Chem [Internet]. 2011;286(13):11047-55. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21258123eng
dcterms.referencesLiggi M, Murgia D, Civolani A, Demelia E, Sorbello O, Demelia L. The relationship between copper and steatosis in Wilson’s disease . Clin Res Hepatol Gastroenterol [Internet]. 2013;37(1):36-40. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S2210740112001192eng
dcterms.referencesMuchenditsi A, Yang H, Hamilton JP, Koganti L, Housseau F, Aronov L, et al. Targeted inactivation of copper transporter Atp7b in hepatocytes causes liver steatosis and obesity in mice . Am J Physiol Liver Physiol [Internet]. 2017;313(1):G39-49. Disponible en: http://www.physiology.org/doi/10.1152/ajpgi.00312.2016eng
dcterms.referencesZhang H, Yan C, Yang Z, Zhang W, Niu Y, Li X, et al. Alterations of serum trace elements in patients with type 2 diabetes . J Trace Elem Med Biol [Internet]. 2017;40:91-6. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0946672X16302462eng
dcterms.referencesStättermayer AF, Traussnigg S, Aigner E, Kienbacher C, Huber-Schönauer U, Steindl-Munda P, et al. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome . J Trace Elem Med Biol [Internet]. 2017;39:100-7. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0946672X16302218eng
dcterms.referencesAigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, et al. A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease . Am J Gastroenterol [Internet]. 2010;105(9):1978-85. Disponible en: http://insights.ovid.com/crossref?an=00000434-201009000-00013eng
dcterms.referencesPierson H, Muchenditsi A, Kim B-E, Ralle M, Zachos N, Huster D, et al. The Function of ATPase Copper Transporter ATP7B in Intestine . Gastroenterology [Internet]. 2018;154(1):168-180.e5. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0016508517361784eng
dcterms.referencesDas A, Sudhahar V, Chen G-F, Kim HW, Youn S-W, Finney L, et al. Endothelial Antioxidant-1: a Key Mediator of Copper-dependent Wound Healing in vivo . Sci Rep [Internet]. 2016;6(1):33783. Disponible en: http://www.nature.com/articles/srep33783eng
dcterms.referencesJurevics H, Hostettler J, Muse ED, Sammond DW, Matsushima GK, Toews AD, et al. Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain . J Neurochem [Internet]. 2001;77(4):1067-76. Disponible en: http://doi.wiley.com/10.1046/j.1471-4159.2001.00310.xeng
dcterms.referencesUrso E, Maffia M. Behind the Link between Copper and Angiogenesis: Established Mechanisms and an Overview on the Role of Vascular Copper Transport Systems . J Vasc Res [Internet]. 2015;52(3):172-96. Disponible en: https://www.karger.com/Article/FullText/438485eng
dcterms.referencesJain S, Cohen J, Ward MM, Kornhauser N, Chuang E, Cigler T, et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse . Ann Oncol [Internet]. 2013;24(6):1491-8. Disponible en: https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mds654eng
dcterms.referencesMounajjed T, Oxentenko AS, Qureshi H, Smyrk TC. Revisiting the Topic of Histochemically Detectable Copper in Various Liver Diseases With Special Focus on Venous Outflow Impairment . Am J Clin Pathol [Internet]. 2013;139(1):79-86. Disponible en: https://academic.oup.com/ajcp/article/139/1/79/1766367eng
dcterms.referencesHuster D. Structural and metabolic changes in Atp7b −/− mouse liver and potential for new interventions in Wilson’s disease . Ann N Y Acad Sci [Internet]. 2014;1315(1):37-44. Disponible en: http://doi.wiley.com/10.1111/nyas.12337eng
dcterms.referencesLang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide . Nat Med [Internet]. 2007;13(2):164-70. Disponible en: http://www.nature.com/articles/nm1539eng
dcterms.referencesSternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson’s disease . Gastroenterology [Internet]. 1968;55(3):354-67. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/5675366eng
dcterms.referencesWalshe JM, Potter G. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson’s Disease and various control groups . Q J Med [Internet]. 1977;46(184):445-62. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/413153eng
dcterms.referencesMikol J, Vital C, Wassef M, Chappuis P, Poupon J, Lecharpentier M, et al. Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases . Acta Neuropathol [Internet]. 2005;110(5):451-8. Disponible en: http://link.springer.com/10.1007/s00401-005-1061-1eng
dcterms.referencesHoroupian DS, Sternlieb I, Scheinberg IH. Neuropathological findings in penicillamine-treated patients with Wilson’s disease . Clin Neuropathol [Internet]. 7(2):62-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/3390974eng
dcterms.referencesScheiber IF, Dringen R. Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocytes . Neurosci Lett [Internet]. 2011;498(1):42-6. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0304394011005428eng
dcterms.referencesMeenakshi-Sundaram S, Mahadevan A, Taly AB, Arunodaya GR, Swamy HS, Shankar SK. Wilson’s disease: a clinico-neuropathological autopsy study . J Clin Neurosci [Internet]. 2008;15(4):409-17. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18242093eng
dcterms.referencesDusek P, Bahn E, Litwin T, Jabłonka-Salach K, Łuciuk A, Huelnhagen T, et al. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study . Neuropathol Appl Neurobiol [Internet]. 2017;43(6):514-32. Disponible en: http://doi.wiley.com/10.1111/nan.12341eng
dcterms.referencesSvetel M, Kozić D, Stefanova E, Semnic R, Dragasevic N, Kostic VS. Dystonia in Wilson’s disease . Mov Disord [Internet]. 2001;16(4):719-23. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11481698eng
dcterms.referencesIwański S, Seniów J, Leśniak M, Litwin T, Członkowska A. Diverse attention deficits in patients with neurologically symptomatic and asymptomatic Wilson’s disease . Neuropsychology [Internet]. 2015;29(1):25-30. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24885450eng
dcterms.referencesSüdmeyer M, Pollok B, Hefter H, Gross J, Butz M, Wojtecki L, et al. Synchronized brain network underlying postural tremor in Wilson’s disease . Mov Disord [Internet]. 2006;21(11):1935-40. Disponible en: http://doi.wiley.com/10.1002/mds.21104eng
dcterms.referencesPrashanth LK, Sinha S, Taly AB, A.Mahadevan, Vasudev MK, Shankar SK. Spectrum of epilepsy in Wilson’s disease with electroencephalographic, MR imaging and pathological correlates . J Neurol Sci [Internet]. 2010;291(1-2):44-51. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0022510X10000158eng
dcterms.referencesLangwińska-Wośko E, Litwin T, Dzieżyc K, Karlinski M, Członkowska A. Optical coherence tomography as a marker of neurodegeneration in patients with Wilson’s disease . Acta Neurol Belg [Internet]. 2017;117(4):867-71. Disponible en: http://link.springer.com/10.1007/s13760-017-0788-5eng
dcterms.referencesLangwińska-Wośko E, Litwin T, Szulborski K, Członkowska A. Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson’s disease . Metab Brain Dis [Internet]. 2016;31(2):405-15. Disponible en: http://link.springer.com/10.1007/s11011-015-9776-8eng
dcterms.referencesMiranda M, Venegas P. El anillo de Kayser-Fleischer como signo diagnóstico en la Enfermedad de Wilson . Rev Chil Neuropsiquiatr [Internet]. 2002;40(2). Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272002000200005&lng=en&nrm=iso&tlng=enspa
dcterms.referencesSullivan CA. Dense Kayser-Fleischer ring in asymptomatic Wilson’s disease (hepatolenticular degeneration). Br J Ophthalmol [Internet]. 2002;86(1):114-114. Disponible en: http://bjo.bmj.com/cgi/doi/10.1136/bjo.86.1.114eng
dcterms.referencesPadilla Galindo H, Serrano A, Polo A, García R, Acosta Reyes J, Navarro-Jiménez E. Caracterización clínica-epidemiológica de las glomerulonefritis primarias un centro de referencia de caribe colombiano, en niños menores de 15 años, de enero 2008 a diciembre 2013. Rev Colomb Nefrol [Internet]. 2014;1. Disponible en: http://www.revistanefrologia.org/index.php/rcn/article/view/152spa
dcterms.referencesAroca-Martínez G, González-Torres HJ, Domínguez-Vargas A, Fontalvo-Pastorizo J, Silva-Díaz D, Cadena-Bonfanti A. Respuesta a la farmacoterapia en pacientes con glomerulonefritis membranoproliferativa en una clínica de Barranquilla, Colombia. 2007-2014. Rev la Fac Med [Internet]. 1 de julio de 2018;66(3):301-5. Disponible en: https://revistas.unal.edu.co/index.php/revfacmed/article/view/63178spa
dcterms.referencesCastillo Parodi L, Navarro Jiménez, Eduardo Arango Quiroz Y, López Avendaño, Anderson Mejía Varela V, González Torres, Henry J Aroca Martínez G. Asociación de obesidad con la Enfermedad Renal Crónica de pacientes atendidos en la Clínica de la Costa. 2005-2014. Rev Colomb Nefrol [Internet]. 2016;3(1). Disponible en: http://www.revistanefrologia.org/index.php/rcn/article/view/217spa
dcterms.referencesWalshe JM. The acute haemolytic syndrome in Wilson’s disease--a review of 22 patients. QJM [Internet]. 2013;106(11):1003-8. Disponible en: https://academic.oup.com/qjmed/article-lookup/doi/10.1093/qjmed/hct137eng
dcterms.referencesForman SJ, Kumar KS, Redeker AG, Hochstein P. Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms . Am J Hematol [Internet]. 1980;9(3):269-75. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/7234865eng
dcterms.referencesBenders AA, Li J, Lock RA, Bindels RJ, Bonga SE, Veerkamp JH. Copper toxicity in cultured human skeletal muscle cells: the involvement of Na+/K(+)-ATPase and the Na+/Ca(2+)-exchanger . Pflugers Arch [Internet]. 1994;428(5-6):461-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/7838667eng
dcterms.referencesHogland HC, Goldstein NP. Hematologic (cytopenic) manifestations of Wilson’s disease (hepatolenticular degeneration) . Mayo Clin Proc [Internet]. 1978;53(8):498-500. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/682676eng
dcterms.referencesDzieżyc K, Litwin T, Członkowska A. Other organ involvement and clinical aspects of Wilson disease . Handb Clin Neurol [Internet]. 2017;142:157-69. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28433099eng
dcterms.referencesZhuang X-H, Mo Y, Jiang X-Y, Chen S-M. Analysis of renal impairment in children with Wilson’s disease . World J Pediatr [Internet]. 2008;4(2):102-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18661763eng
dcterms.referencesWeiss KH, Van de Moortele M, Gotthardt DN, Pfeiffenberger J, Seeßle J, Ullrich E, et al. Bone demineralisation in a large cohort of Wilson disease patients . J Inherit Metab Dis [Internet]. 2015;38(5):949-56. Disponible en: http://doi.wiley.com/10.1007/s10545-015-9815-yeng
dcterms.referencesMenerey KA, Eider W, Brewer GJ, Braunstein EM, Schumacher HR, Fox IH. The arthropathy of Wilson’s disease: clinical and pathologic features. J Rheumatol [Internet]. 1988;15(2):331-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/3361541eng
dcterms.referencesBuksińska-Lisik M, Litwin T, Pasierski T, Członkowska A. Cardiac assessment in Wilson’s disease patients based on electrocardiography and echocardiography examination. Arch Med Sci [Internet]. 2019;15(4):857-64. Disponible en: https://www.termedia.pl/doi/10.5114/aoms.2017.69728eng
dcterms.referencesLewis D, Pilankatta R, Inesi G, Bartolommei G, Moncelli MR, Tadini-Buoninsegni F. Distinctive Features of Catalytic and Transport Mechanisms in Mammalian Sarco-endoplasmic Reticulum Ca 2+ ATPase (SERCA) and Cu + (ATP7A/B) ATPases. J Biol Chem [Internet]. 2012;287(39):32717-27. Disponible en: http://www.jbc.org/lookup/doi/10.1074/jbc.M112.373472eng
dcterms.referencesPilankatta R, Lewis D, Inesi G. Involvement of Protein Kinase D in Expression and Trafficking of ATP7B (Copper ATPase) . J Biol Chem [Internet]. 2011;286(9):7389-96. Disponible en: http://www.jbc.org/lookup/doi/10.1074/jbc.M110.171454eng
dcterms.referencesHatori Y, Hirata A, Toyoshima C, Lewis D, Pilankatta R, Inesi G. Intermediate Phosphorylation Reactions in the Mechanism of ATP Utilization by the Copper ATPase (CopA) of Thermotoga maritima . J Biol Chem [Internet]. 2008;283(33):22541-9. Disponible en: http://www.jbc.org/lookup/doi/10.1074/jbc.M802735200eng
dcterms.referencesInesi G, Pilankatta R, Tadini-Buoninsegni F. Biochemical characterization of P-type copper ATPases. Biochem J [Internet]. 2014;463(2):167-76. Disponible en: https://portlandpress.com/biochemj/article/463/2/167/48328/Biochemical-characterization-of-Ptype-coppereng
dcterms.referencesKaplan JH, Lutsenko S. Copper Transport in Mammalian Cells: Special Care for a Metal with Special Needs. J Biol Chem [Internet]. 2009;284(38):25461-5. Disponible en: http://www.jbc.org/lookup/doi/10.1074/jbc.R109.031286eng
dcterms.referencesGonzález-Guerrero M, Hong D, Argüello JM. Chaperone-mediated Cu + Delivery to Cu + Transport ATPases. J Biol Chem [Internet]. 2009;284(31):20804-11. Disponible en: http://www.jbc.org/lookup/doi/10.1074/jbc.M109.016329eng
dcterms.referencesLa Fontaine S, Mercer JFB. Trafficking of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis . Arch Biochem Biophys [Internet]. 2007;463(2):149-67. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S000398610700210Xeng
dcterms.referencesArgüello JM, Eren E, González-Guerrero M. The structure and function of heavy metal transport P1B-ATPases . BioMetals [Internet]. 2007;20(3-4):233-48. Disponible en: http://link.springer.com/10.1007/s10534-006-9055-6eng
dcterms.referencesArgüello JM. Identification of Ion-Selectivity Determinants in Heavy-Metal Transport P 1B -type ATPases. J Membr Biol [Internet]. 2003;195(2):93-108. Disponible en: http://link.springer.com/10.1007/s00232-003-2048-2eng
dcterms.referencesArnesano F. Metallochaperones and Metal-Transporting ATPases: A Comparative Analysis of Sequences and Structures . Genome Res [Internet]. 2002;12(2):255-71. Disponible en: http://www.genome.org/cgi/doi/10.1101/gr.196802eng
dcterms.referencesLabes A, Schonheit P. Unusual Starch Degradation Pathway via Cyclodextrins in the Hyperthermophilic Sulfate-Reducing Archaeon Archaeoglobus fulgidus Strain 7324 . J Bacteriol [Internet]. 2007;189(24):8901-13. Disponible en: http://jb.asm.org/cgi/doi/10.1128/JB.01136-07eng
dcterms.referencesHarris ED. Cellular Copper Transport and Metabolism . Annu Rev Nutr [Internet]. 2000;20(1):291-310. Disponible en: http://www.annualreviews.org/doi/10.1146/annurev.nutr.20.1.291eng
dcterms.referencesSitthisak S, Kitti T, Boonyonying K, Wozniak D, Mongkolsuk S, Jayaswal RK. McsA and the roles of metal-binding motif in Staphylococcus aureus . FEMS Microbiol Lett [Internet]. 2012;327(2):126-33. Disponible en: https://academic.oup.com/femsle/article-lookup/doi/10.1111/j.1574-6968.2011.02468.xeng
dcterms.referencesWu C-C, Rice WJ, Stokes DL. Structure of a Copper Pump Suggests a Regulatory Role for Its Metal-Binding Domain . Structure [Internet]. 2008;16(6):976-85. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0969212608001512eng
dcterms.referencesTsuda T, Toyoshima C. Nucleotide recognition by CopA, a Cu+-transporting P-type ATPase . EMBO J [Internet]. 2009;28(12):1782-91. Disponible en: http://emboj.embopress.org/cgi/doi/10.1038/emboj.2009.143eng
dcterms.referencesSazinsky MH, Agarwal S, Argüello JM, Rosenzweig AC. Structure of the Actuator Domain from the Archaeoglobus fulgidus Cu + -ATPase . Biochemistry [Internet]. 2006;45(33):9949-55. Disponible en: https://pubs.acs.org/doi/10.1021/bi0610045eng
dcterms.referencesWu C-C, Allen GS, Stokes DL. Structure of CopA from Archaeoglobus Fulgidus by Cryoelectron Microscopy . Biophys J [Internet]. 2010;98(3):168a. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S000634950902712Xeng
dcterms.referencesVulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase . Nat Genet [Internet]. 1993;3(1):7-13. Disponible en: http://www.nature.com/articles/ng0193-7eng
dcterms.referencesPetrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions . Hum Mol Genet [Internet]. 1994;3(9):1647-56. Disponible en: https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/3.9.1647eng
dcterms.referencesLa Fontaine S, Mercer JFB. Trafficking of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis . Arch Biochem Biophys [Internet]. 2007;463(2):149-67. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S000398610700210Xeng
dcterms.referencesGourdon P, Sitsel O, Karlsen JL, Møller LB, Nissen P. Structural models of the human copper P-type ATPases ATP7A and ATP7B. Biol Chem [Internet]. 2012;393(4):205-16. Disponible en: http://www.degruyter.com/view/j/bchm.2012.393.issue-4/hsz-2011-0249/hsz-2011-0249.xmleng
dcterms.referencesBadenas C. Utilidad del estudio genético en el diagnóstico e intervención familiar en la enfermedad de Wilson . En: Enfermedad de Wilson [Internet]. Barcelona; 2015. Disponible en: http://aeeh.es/wp-content/uploads/2015/12/1.-Celia-Badenas.pdfspa
dcterms.referencesHuman Gene Mutation Database. The Human Gene Mutation Database (HGMD) [Internet]. Disponible en: http://www.hgmd.orgeng
dcterms.referencesThe Universal Mutation Database. The ATP7B mutations database [Internet]. Disponible en: http://www.umd.be/ATP7B/eng
dcterms.referencesUniversity of Alberta. Wilson Disease Mutation Database [Internet]. Disponible en: http://www.wilsondisease.med.ualberta.ca/eng
dcterms.referencesFirneisz G, Lakatos PL, Szalay F, Polli C, Glant TT, Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet [Internet]. 2002;108(1):23-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11857545eng
dcterms.referencesde Bie P, van de Sluis B, Burstein E, van de Berghe PVE, Muller P, Berger R, et al. Distinct Wilson’s Disease Mutations in ATP7B Are Associated With Enhanced Binding to COMMD1 and Reduced Stability of ATP7B . Gastroenterology [Internet]. 2007;133(4):1316-26. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S001650850701400Xeng
dcterms.referencesHuster D, Kühne A, Bhattacharjee A, Raines L, Jantsch V, Noe J, et al. Diverse Functional Properties of Wilson Disease ATP7B Variants . Gastroenterology [Internet]. 2012;142(4):947-956.e5. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0016508512000169eng
dcterms.referencesFerenci P, Roberts EA. Defining Wilson Disease Phenotypes: From the Patient to the Bench and Back Again . Gastroenterology [Internet]. 2012;142(4):692-6. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0016508512002491eng
dcterms.referencesMerle U, Weiss KH, Eisenbach C, Tuma S, Ferenci P, Stremmel W. Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease . BMC Gastroenterol [Internet]. 2010;10(1):8. Disponible en: https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-10-8eng
dcterms.referencesOkada T, Shiono Y, Kaneko Y, Miwa K, Hasatani K, Hayashi Y, et al. High prevalence of fulminant hepatic failure among patients with mutant alleles for truncation of ATP7B in Wilson’s disease . Scand J Gastroenterol [Internet]. 2010;45(10):1232-7. Disponible en: http://www.tandfonline.com/doi/full/10.3109/00365521.2010.492527eng
dcterms.referencesUsta J, Wehbeh A, Rida K, El-Rifai O, Estiphan TA, Majarian T, et al. Phenotype-Genotype Correlation in Wilson Disease in a Large Lebanese Family: Association of c.2299insC with Hepatic and of p. Ala1003Thr with Neurologic Phenotype . Dmitriev OY, editor. PLoS One [Internet]. 2014;9(11):e109727. Disponible en: https://dx.plos.org/10.1371/journal.pone.0109727eng
dcterms.referencesCocoş R, Şendroiu A, Schipor S, Bohîlţea LC, Şendroiu I, Raicu F. Genotype-Phenotype Correlations in a Mountain Population Community with High Prevalence of Wilson’s Disease: Genetic and Clinical Homogeneity . Dermaut B, editor. PLoS One [Internet]. 2014;9(6):e98520. Disponible en: https://dx.plos.org/10.1371/journal.pone.0098520eng
dcterms.referencesMukherjee S, Dutta S, Majumdar S, Biswas T, Jaiswal P, Sengupta M, et al. Genetic defects in Indian Wilson disease patients and genotype–phenotype correlation . Parkinsonism Relat Disord [Internet]. 2014;20(1):75-81. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1353802013003519eng
dcterms.referencesFrydman M, Bonne-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus . Proc Natl Acad Sci [Internet]. 1985;82(6):1819-21. Disponible en: http://www.pnas.org/cgi/doi/10.1073/pnas.82.6.1819eng
dcterms.referencesBull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene . Nat Genet [Internet]. 1993;5(4):327-37. Disponible en: http://www.nature.com/articles/ng1293-327eng
dcterms.referencesYamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease . Biochem Biophys Res Commun [Internet]. 1993;197(1):271-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8250934eng
dcterms.referencesPetrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions . Hum Mol Genet [Internet]. septiembre de 1994;3(9):1647-56. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/7833924eng
dcterms.referencesFanni D, Pilloni L, Orrù S, Coni P, Liguori C, Serra S, et al. Expression of ATP7B in normal human liver . Eur J Histochem [Internet]. 49(4):371-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16377579eng
dcterms.referencesGupta A, Chattopadhyay I, Dey S, Nasipuri P, Das SK, Gangopadhyay PK, et al. Molecular Pathogenesis of Wilson Disease Among Indians: A Perspective on Mutation Spectrum in ATP7B gene, Prevalent Defects, Clinical Heterogeneity and Implication Towards Diagnosis . Cell Mol Neurobiol [Internet]. 2007;27(8):1023-33. Disponible en: http://link.springer.com/10.1007/s10571-007-9192-7eng
dcterms.referencesFerenci P, Członkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C, et al. Late-onset Wilson’s disease . Gastroenterology [Internet]. 2007;132(4):1294-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17433323eng
dcterms.referencesAggarwal A, Chandhok G, Todorov T, Parekh S, Tilve S, Zibert A, et al. Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations . Ann Hum Genet [Internet]. 2013;77(4):299-307. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23551039eng
dcterms.referencesGupta A, Aikath D, Neogi R, Datta S, Basu K, Maity B, et al. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype–phenotype correlation in Indian patients . Hum Genet [Internet]. 2005;118(1):49-57. Disponible en: http://link.springer.com/10.1007/s00439-005-0007-yeng
dcterms.referencesKumar S, Thapa B, Kaur G, Prasad R. Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper ATPase activity . Mol Cell Biochem [Internet]. 2007;294(1-2):1-10. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17160357eng
dcterms.referencesSanthosh S, Shaji R V, Eapen CE, Jayanthi V, Malathi S, Chandy M, et al. ATP7B mutations in families in a predominantly Southern Indian cohort of Wilson’s disease patients . Indian J Gastroenterol [Internet]. 25(6):277-82. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17264425eng
dcterms.referencesOkada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, et al. Mutational analysis ofATP7Band genotype-phenotype correlation in Japanese with Wilson’s disease . Hum Mutat [Internet]. 2000;15(5):454-62. Disponible en: http://doi.wiley.com/10.1002/%28SICI%291098-1004%28200005%2915%3A5%3C454%3A%3AAID-HUMU7%3E3.0.CO%3B2-Jeng
dcterms.referencesAl Jumah M, Majumdar R, Al Rajeh S, Awada A, Al Zaben A, Al Traif I, et al. A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations . Eur J Neurol [Internet]. 2004;11(2):121-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/14748773eng
dcterms.referencesStättermayer AF, Traussnigg S, Dienes H-P, Aigner E, Stauber R, Lackner K, et al. Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations . J Hepatol [Internet]. 2015;63(1):156-63. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0168827815000719eng
dcterms.referencesPingitore P, Pirazzi C, Mancina RM, Motta BM, Indiveri C, Pujia A, et al. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function . Biochim Biophys Acta - Mol Cell Biol Lipids [Internet]. 2014;1841(4):574-80. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1388198113002795eng
dcterms.referencesSchiefermeier M. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson’s disease . Brain [Internet]. 2000;123(3):585-90. Disponible en: https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/123.3.585eng
dcterms.referencesLitwin T, Gromadzka G, Członkowska A. Apolipoprotein E gene (APOE) genotype in Wilson’s disease: Impact on clinical presentation . Parkinsonism Relat Disord [Internet]. 2012;18(4):367-9. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1353802011004305eng
dcterms.referencesStuehler B, Reichert J, Stremmel W, Schaefer M. Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients . J Mol Med [Internet]. 2004;82(9). Disponible en: http://link.springer.com/10.1007/s00109-004-0557-9eng
dcterms.referencesLovicu M, Dessì V, Lepori MB, Zappu A, Zancan L, Giacchino R, et al. The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol [Internet]. 24 de julio de 2006;41(6):582-7. Disponible en: http://link.springer.com/10.1007/s00535-006-1807-0eng
dcterms.referencesWu Z-Y, Zhao G-X, Chen W-J, Wang N, Wan B, Lin M-T, et al. Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease . J Mol Med [Internet]. 2006;84(5):438-42. Disponible en: http://link.springer.com/10.1007/s00109-005-0036-yeng
dcterms.referencesSimon I, Schaefer M, Reichert J, Stremmel W. Analysis of the human Atox 1 homologue in Wilson patients . World J Gastroenterol [Internet]. 2008;14(15):2383. Disponible en: http://www.wjgnet.com/1007-9327/full/v14/i15/2383.htmeng
dcterms.referencesLee BH, Kim JH, Lee SY, Jin HY, Kim K-J, Lee J-J, et al. Distinct clinical courses according to presenting phenotypes and their correlations to ATP7B mutations in a large Wilson’s disease cohort . Liver Int [Internet]. 2011;31(6):831-9. Disponible en: http://doi.wiley.com/10.1111/j.1478-3231.2011.02503.xeng
dcterms.referencesBost M, Piguet-Lacroix G, Parant F, Wilson CMR. Molecular analysis of Wilson patients: Direct sequencing and MLPA analysis in the ATP7B gene and Atox1 and COMMD1 gene analysis . J Trace Elem Med Biol [Internet]. 2012;26(2-3):97-101. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0946672X12000806eng
dcterms.referencesSenzolo M, Loreno M, Fagiuoli S, Zanus G, Canova D, Masier A, et al. Different neurological outcome of liver transplantation for Wilson’s disease in two homozygotic twins . Clin Neurol Neurosurg [Internet]. 2007;109(1):71-5. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0303846706000126eng
dcterms.referencesKegley KM, Sellers MA, Ferber MJ, Johnson MW, Joelson DW, Shrestha R. Fulminant Wilson’s Disease Requiring Liver Transplantation in One Monozygotic Twin Despite Identical Genetic Mutation . Am J Transplant [Internet]. 2010;10(5):1325-9. Disponible en: http://doi.wiley.com/10.1111/j.1600-6143.2010.03071.xeng
dcterms.referencesCzłonkowska A, Gromadzka G, Chabik G. Monozygotic female twins discordant for phenotype of Wilson’s disease. Mov Disord [Internet]. 2009;24(7):1066-9. Disponible en: http://doi.wiley.com/10.1002/mds.22474eng
dcterms.referencesBethin KE, Cimato TR, Ettinger MJ. Copper Binding to Mouse Liver S -Adenosylhomocysteine Hydrolase and the Effects of Copper on Its Levels . J Biol Chem [Internet]. 1995;270(35):20703-11. Disponible en: http://www.jbc.org/lookup/doi/10.1074/jbc.270.35.20703eng
dcterms.referencesDelgado M, Pérez-Miguelsanz J, Garrido F, Rodríguez-Tarduchy G, Pérez-Sala D, Pajares MA. Early effects of copper accumulation on methionine metabolism . Cell Mol Life Sci [Internet]. 2008;65(13):2080-90. Disponible en: http://link.springer.com/10.1007/s00018-008-8201-4eng
dcterms.referencesMedici V, Shibata NM, Kharbanda KK, LaSalle JM, Woods R, Liu S, et al. Wilson’s disease: Changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease . Hepatology [Internet]. 2013;57(2):555-65. Disponible en: http://doi.wiley.com/10.1002/hep.26047eng
dcterms.referencesMedici V, Shibata NM, Kharbanda KK, Islam MS, Keen CL, Kim K, et al. Maternal choline modifies fetal liver copper, gene expression, DNA methylation, and neonatal growth in the tx-j mouse model of Wilson disease . Epigenetics [Internet]. 2014;9(2):286-96. Disponible en: http://www.tandfonline.com/doi/abs/10.4161/epi.27110eng
dcterms.referencesBem RS de, Raskin S, Muzzillo DA, Deguti MM, Cancado ELR, Araujo TF, et al. Wilson’s disease in Southern Brazil: genotype-phenotype correlation and description of two novel mutations in ATP7B gene . Arq Neuropsiquiatr [Internet]. 2013;71(8):503-7. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000800503&lng=en&tlng=eneng
dcterms.referencesMachado AAC, Deguti MM, Genschel J, Cançado ELR, Bochow B, Schmidt H, et al. Neurological manifestations and ATP7B mutations in Wilson’s disease . Parkinsonism Relat Disord [Internet]. 2008;14(3):246-9. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S135380200700171Xeng
dcterms.referencesGupta S. Cell therapy to remove excess copper in Wilson’s disease . Ann N Y Acad Sci [Internet]. 2014;1315(1):70-80. Disponible en: http://doi.wiley.com/10.1111/nyas.12450eng
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Resolución 8430 de 1993. Colombia; 1993 p. 12.spa
dcterms.referencesAsociación Médica Mundial. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. 1964 p. 6.spa
dcterms.referencesNagel J, Miralles S. Enfermedad de Wilson: comienzo con síntomas psiquiátricos. Hallazgos en resonancia magnética encefálica . Rev Argentina Radiol [Internet]. 2007;71(3):267-71. Disponible en: https://www.redalyc.org/articulo.oa?id=382538453004spa
dcterms.referencesPulido JN, Alfonso L, Medina ADC, Guillermo J, Tamayo S, Medina JCR. Enfermedad de Wilson. Acta Médica Colomb [Internet]. 2002; Disponible en: http://actamedicacolombiana.com/anexo/articulos/03-2002-09.htmspa
dcterms.referencesHa-Hao D, Hefter H, Stremmel W, Castañeda-Guillot C, Hernández AH, Cox DW, et al. His1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype. Eur J Hum Genet [Internet]. 1998;6(6):616-23. Disponible en: http://www.nature.com/articles/5200237eng
dcterms.referencesWhisstock JC, Lesk AM. Prediction of protein function from protein sequence and structure . Q Rev Biophys [Internet]. 2003;36(3):307-40. Disponible en: https://www.cambridge.org/core/product/identifier/S0033583503003901/type/journal_articleeng
dcterms.referencesMargarit E, Bach V, Gómez D, Bruguera M, Jara P, Queralt R, et al. Mutation analysis of Wilson disease in the Spanish population - identification of a prevalent substitution and eight novel mutations in the ATP7B gene . Clin Genet [Internet]. 2005;68(1):61-8. Disponible en: http://doi.wiley.com/10.1111/j.1399-0004.2005.00439.xeng
dcterms.referencesBrage A, Tomé S, García A, Carracedo Á, Salas A. Clinical and molecular characterization of Wilson disease in Spanish patients . Hepatol Res [Internet]. 2007;37(1):18-26. Disponible en: http://doi.wiley.com/10.1111/j.1872-034X.2007.00010.xeng
dcterms.referencesArnab Gupta, Svetlana Lutsenko. Evolution of Copper Transporting ATPases in Eukaryotic Organisms . Curr Genomics [Internet]. 2012;13(2):124-33. Disponible en: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1389-2029&volume=13&issue=2&spage=124eng
dcterms.referencesPríncipe Felipe. Genetics and Genomics of Neuromuscular and Neurodegenerative Diseases . [Internet]. Disponible en: http://espinos.cipf.es/images/articulos/ATP7B_Tabla_Mutaciones.pdfeng
dcterms.referencesParadisi I, De Freitas L, Arias S. Most frequent mutation c.3402delC (p.Ala1135GlnfsX13) among Wilson disease patients in Venezuela has a wide distribution and two old origins . Eur J Med Genet [Internet]. 2015;58(2):59-65. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1769721214002195eng
dcterms.referencesLoudianos G, Dessì V, Lovicu M, Angius A, Kanavakis E, Tzetis M, et al. Haplotype and mutation analysis in Greek patients with Wilson disease . Eur J Hum Genet [Internet]. 1998;6(5):487-91. Disponible en: http://www.nature.com/articles/5200219eng
dcterms.referencesLi Y-Q, Zhang X-Y, Chen J, Yin J-Y, Li X-P. ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients . J Cancer Res Ther [Internet]. 2018;14(4):881. Disponible en: http://www.cancerjournal.net/text.asp?2018/14/4/881/235102eng
dcterms.referencesAlemany S, Vilor-Tejedor N, Bustamante M, Álvarez-Pedrerol M, Rivas I, Forns J, et al. Interaction between airborne copper exposure and ATP7B polymorphisms on inattentiveness in scholar children . Int J Hyg Environ Health [Internet]. 2017;220(1):51-6. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1438463916302577eng
dcterms.referencesSquitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, et al. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency . Mol Neurobiol [Internet]. 2017;54(1):671-81. Disponible en: http://link.springer.com/10.1007/s12035-015-9664-6eng
dcterms.referencesAloisio M, Licastro D, Caenazzo L, Torboli V, D’eustacchio A, Severini GM, et al. A technical application of quantitative next generation sequencing for chimerism evaluation . Mol Med Rep [Internet]. 2016;14(4):2967-74. Disponible en: https://www.spandidos-publications.com/10.3892/mmr.2016.5593eng
dcterms.referencesHua R, Hua F, Jiao Y, Pan Y, Yang X, Peng S, et al. Mutational analysis of ATP7B in Chinese Wilson disease patients . Am J Transl Res [Internet]. 2016;8(6):2851-61. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27398169eng
dcterms.referencesLi X-P, Yin J-Y, Wang Y, He H, Li X, Gong W-J, et al. The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients . Tumor Biol [Internet]. 2014;35(8):8259-65. Disponible en: http://link.springer.com/10.1007/s13277-014-2072-0eng
dcterms.referencesSquitti R, Polimanti R, Bucossi S, Ventriglia M, Mariani S, Manfellotto D, et al. Linkage Disequilibrium and Haplotype Analysis of the ATP7B Gene in Alzheimer’s Disease . Rejuvenation Res [Internet]. febrero de 2013;16(1):3-10. Disponible en: https://www.liebertpub.com/doi/10.1089/rej.2012.1357eng
dcterms.referencesBucossi S, Polimanti R, Mariani S, Ventriglia M, Bonvicini C, Migliore S, et al. Association of K832R and R952K SNPs of Wilson’s Disease Gene with Alzheimer’s Disease . J Alzheimer’s Dis [Internet]. 2012;29(4):913-9. Disponible en: http://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/JAD-2012-111997eng
dcterms.referencesWu Z-Y, Wang N, Lin M-T, Fang L, Murong S-X, Yu L. Mutation Analysis and the Correlation Between Genotype and Phenotype of Arg778Leu Mutation in Chinese Patients With Wilson Disease . Arch Neurol [Internet]. 2001;58(6):971. Disponible en: http://archneur.jamanetwork.com/article.aspx?doi=10.1001/archneur.58.6.971eng
dcterms.referencesSquitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, et al. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency. Mol Neurobiol [Internet]. 12 de enero de 2017;54(1):671-81. Disponible en: http://link.springer.com/10.1007/s12035-015-9664-6eng
dcterms.referencesLavrov A V., Chelysheva EY, Smirnikhina SA, Shukhov OA, Turkina AG, Adilgereeva EP, et al. Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia . BMC Genet [Internet]. 2016;17(S1):S14. Disponible en: http://bmcgenet.biomedcentral.com/articles/10.1186/s12863-015-0308-7eng
dcterms.referencesTecza K, Pamula-Pilat J, Kolosza Z, Radlak N, Grzybowska E. Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy . J Exp Clin Cancer Res [Internet]. 2015;34(1):2. Disponible en: http://jeccr.biomedcentral.com/articles/10.1186/s13046-015-0124-yeng
dcterms.referencesThomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences . Nat Genet [Internet]. 1995;9(2):210-7. Disponible en: http://www.nature.com/articles/ng0295-210eng
dcterms.referencesCox DW, Prat L, Walshe JM, Heathcote J, Gaffney D. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry . Hum Mutat [Internet]. 2005;26(3):280-280. Disponible en: http://doi.wiley.com/10.1002/humu.9358eng
dcterms.referencesOlsson C, Waldenström E, Westermark K, Landegren U, Syvänen A-C. Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples . Eur J Hum Genet [Internet]. 2000;8(12):933-8. Disponible en: http://www.nature.com/articles/5200566eng
dcterms.referencesFigus A, Angius A, Loudianos G, Bertini C, Dessi V, Loi A, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations . Am J Hum Genet [Internet]. 1995;57(6):1318-24. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1801406eng
dcterms.referencesTomić A, Dobricić V, Novaković I, Svetel M, Pekmezović T, Kresojević N, et al. Mutational analysis of ATP7B gene and the genotype-phenotype correlation in patients with Wilson’s disease in Serbia . Vojnosanit Pregl [Internet]. 2013;70(5):457-62. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23789284eng
dcterms.referencesKucinskas L, Jeroch J, Vitkauskiene A, Sakalauskas R, Petrenkiene V, Kucinskas V, et al. High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson’s disease. World J Gastroenterol [Internet]. 2008;14(38):5876. Disponible en: http://www.wjgnet.com/1007-9327/full/v14/i38/5876.htmeng
dcterms.referencesLiu X-Q. Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease . World J Gastroenterol [Internet]. 2004;10(4):590. Disponible en: http://www.wjgnet.com/1007-9327/full/v10/i4/590.htmeng
dcterms.referencesKumari N, Kumar A, Thapa BR, Modi M, Pal A, Prasad R. Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications . Hum Mutat [Internet]. 2018;39(12):1926-41. Disponible en: http://doi.wiley.com/10.1002/humu.23614eng
dcterms.referencesLeung M, Wu Lanzafame J, Medici V. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations. J Investig Med High Impact Case Reports [Internet]. 10 de enero de 2020;8:232470961989687. Disponible en: http://journals.sagepub.com/doi/10.1177/2324709619896876eng
dcterms.referencesJacquelet E, Beretti J, De-Tassigny A, Girardot-Tinant N, Wenisch E, Lachaux A, et al. L’observance dans la maladie de Wilson : intérêt d’un suivi rapproché au long cours. La Rev Médecine Interne [Internet]. marzo de 2018;39(3):155-60. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0248866317311827eng
dcterms.referencesGonzalez CP, Illera EF, Cárdenas CL, Jimenez EN, Mendez PG, Peralta VV, et al. Screening of Anxiety and Depression in Patients With Fibromyalgia From 18 to 65 Years Old and Its Relationship With the Severity of Fibromyalgia and Quality of Life. Glob J Health Sci [Internet]. 5 de noviembre de 2018;10(12):12. Disponible en: http://www.ccsenet.org/journal/index.php/gjhs/article/view/0/37317eng
dcterms.referencesReales JM, Navarro-Jiménez E, Laborde-Cárdenas C, Gómez-Méndez P, Narvaez LCL. Implementation Plan of the Clinical Practice Guideline for the Early Detection, Diagnosis and Treatment of Patients With Alcohol Abuse or Dependence in a Colombian Hospital. Glob J Health Sci [Internet]. 11 de agosto de 2018;10(9):89. Disponible en: http://www.ccsenet.org/journal/index.php/gjhs/article/view/76504eng
dcterms.referencesLucía, Rodríguez P, Óscar, Zurriaga Llorens MEGSC, Carbonell C. LA ENFERMEDAD DE WILSON: LAS DIVERSAS PERSPECTIVAS DEL PROFESIONAL SANITARIO, AFECTADO Y FAMILIAR. Rev Esp Salud Publica [Internet]. 2019;93(1). Disponible en: https://www.mscbs.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL93/O_BREVES/RS93C_201904014.pdfspa
dcterms.referencesPoujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med [Internet]. abril de 2019;7(S2):S67-S67. Disponible en: http://atm.amegroups.com/article/view/24633/23691eng
dcterms.referencesValentino PL, Roberts EA, Beer S, Miloh T, Arnon R, Vittorio JM, et al. Management of Wilson Disease Diagnosed in Infancy. J Pediatr Gastroenterol Nutr [Internet]. enero de 2020;1. Disponible en: http://journals.lww.com/10.1097/MPG.0000000000002608eng
dcterms.referencesNavarro-Jimenez EI, Aroca Martínez G, Castillo LA, Gonzalez-Torres H. Membranoproliferative Glomerulonephritis C3 Deposits: Clinicopathological Study. J Am Soc Nephrol. 2015;eng
dcterms.referencesCastillo LA, Navarro-Jimenez EI, López I, Camacho K, Olivero M, Aroca Martínez G, et al. Membranoproliferative Glomerulonephritis C3 deposits: Clinicopathological Study. Amercican J Nephrol [Internet]. 2015;26(2015):459A. Disponible en: https://www.asn-online.org/education/kidneyweek/archives/eng
dcterms.referencesNavarro Jimenez E, Aroca Martínez G, Santos D. Implementación de un modelo de salud renal en red informática para la temprana detección y cuidado de la nefropatía primaria lúpica y glomerulonefritis en la Región Caribe Colombiana. Rev Colomb Nefrol [Internet]. 2014;1. Disponible en: http://www.revistanefrologia.org/index.php/rcn/article/view/145spa
dcterms.referencesCastillo Parodi L, Navarro Jiménez E, Arango Quiroz Y, López Avendaño A, Mejía Varela V, González Torres HJ, et al. Obesity Association with Chronic Renal Disease in Patients attended at Clínica de la Costa. Barranquilla, Colombia. 2005-2014. Rev Colomb Nefrol [Internet]. 1 de enero de 2016;3(1):14-9. Disponible en: http://www.revistanefrologia.org/index.php/rcn/article/view/217/pdfeng
dcterms.referencesPoon K-S, Teo ZH, Yap JH, Koay ES, Tan K. Challenges in molecular diagnosis of Wilson disease: viewpoint from the clinical laboratory. J Clin Pathol [Internet]. 3 de diciembre de 2019;jclinpath-2019-206054. Disponible en: http://jcp.bmj.com/lookup/doi/10.1136/jclinpath-2019-206054eng
dcterms.referencesZhu Q, Zhu K, Wang J, Bian W, Lu J. Relationship between genetic mutations and clinical phenotypes in patients with Wilson disease. Medicine (Baltimore) [Internet]. diciembre de 2019;98(49):e18284. Disponible en: http://journals.lww.com/10.1097/MD.0000000000018284eng
dcterms.referencesJafari SH, Haseli S, Kaffashan S, Saeedi-Moghadam M, Iranpour P, Zeinali-Rafsanjani B. Assessment of the Hallmarks of Wilson Disease in CT Scan Imaging. J Med Imaging Radiat Sci [Internet]. diciembre de 2019; Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1939865419305521eng
dcterms.referencesGawande A, Gupta GK, Gupta A, Wanjari SJ, Goel V, Rathore V, et al. Acute-on-Chronic Liver Failure: Etiology of Chronic and Acute Precipitating Factors and Their Effect on Mortality. J Clin Exp Hepatol [Internet]. noviembre de 2019;9(6):699-703. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0973688319301240eng
dcterms.referencesPinillos-Patiño Y, Herazo-Beltrán Y, Cataño JG, Ávila JR De. Actividad física y calidad de vida en personas con enfermedad renal crónica. Rev Med Chil [Internet]. 2019;147:153-60. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000200153spa
oaire.versioninfo:eu-repo/semantics/acceptedVersionspa
sb.programaMaestría en Genéticaspa
sb.sedeSede Barranquillaspa

Archivos

Colecciones

Maestrías

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca